Showing 1,101 - 1,120 results of 2,284 for search '"Cardiovascular disease"', query time: 0.06s Refine Results
  1. 1101

    Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis by Nevena Skroza, Alessandra Mambrin, Ilaria Proietti, Veronica Balduzzi, Nicoletta Bernardini, Anna Marchesiello, Simone Michelini, Ersilia Tolino, Salvatore Volpe, Patrizia Maddalena, Antonella Ciaramella, Gianfranco Raimondi, Concetta Potenza

    Published 2020-01-01
    “…We found increased sympathetic activity, associated with a higher risk of cardiovascular disease. HS, according to our results, is an independent cardiovascular risk factor.…”
    Get full text
    Article
  2. 1102

    Phenolic-Rich Baccaurea angulata Modulates Inflammatory Biomarkers of Atherosclerosis by Muhammad Ibrahim, Maryam Abimbola Mikail, Idris Adewale Ahmed, Radiah Abdul Ghani

    Published 2018-01-01
    “…Purpose. Cardiovascular disease (CVD) is the leading and the most critical type of chronic disease. …”
    Get full text
    Article
  3. 1103

    Assessing the quality of CKD care using process quality indicators: A scoping review. by Na Zhou, Chengchuan Chen, Yubei Liu, Zhaolan Yu, Aminu K Bello, Yanhua Chen, Ping Liu

    Published 2024-01-01
    “…The presence of diabetes, hypertension, cardiovascular disease, or proteinuria was associated with higher achievement in indicators of monitoring of kidney markers, use of recommended medications, and management of blood pressure and glycemia.…”
    Get full text
    Article
  4. 1104

    An Improved ConvNeXt With Multimodal Transformer for Physiological Signal Classification by Jiajian Zhu, Yue Feng, Qichao Liu, Hong Xu, Yuan Miao, Zhuosheng Lin, Jia Li, Huilin Liu, Ying Xu, Fufeng Li

    Published 2024-01-01
    “…With escalating mortality rates associated with cardiovascular disease, the early detection of arrhythmias assumes ever-increasing significance. …”
    Get full text
    Article
  5. 1105

    Protective Effects of BDNF against C-Reactive Protein-Induced Inflammation in Women by Nicole Noren Hooten, Ngozi Ejiogu, Alan B. Zonderman, Michele K. Evans

    Published 2015-01-01
    “…Since high sensitivity C-reactive protein (hsCRP) is predictive of cardiovascular events, it is important to examine the relationship between hsCRP and other inflammatory and oxidative stress markers linked to cardiovascular disease (CVD) etiology. Previously, we reported that hsCRP induces the oxidative stress adduct 8-oxo-7,8-dihydro-2′deoxyguanosine (8-oxodG) and that these markers are significantly associated in women. …”
    Get full text
    Article
  6. 1106

    Systemic and Local Effects Among Patients With Betel Quid-Related Oral Cancer by Hui-Ching Chuang MD, PhD, FACS, Ming-Hsien Tsai MD, Yu-Tsai Lin MD, MS, FACS, Ming-Huei Chou PhD, Kun-Lin Yang MD, Chih-Yen Chien MD, FACS

    Published 2022-12-01
    “…Following literature review, aside from having a greater total tumor burden and more local diseases in the oral cavity and digestive tract, patients with betel quid-related oral cancer also have more systemic diseases from metabolic syndrome, hypertension, cardiovascular disease, type II diabetes mellitus, and obesity than those without this habit. …”
    Get full text
    Article
  7. 1107

    Serum Matrix Metalloproteinase 9 and Macrophage Migration Inhibitory Factor (MIF) Are Increased in Young Healthy Nonobese Subjects with Positive Family History of Type 2 Diabetes by Agnieszka Nikołajuk, Natalia Matulewicz, Magdalena Stefanowicz, Monika Karczewska-Kupczewska

    Published 2018-01-01
    “…Insulin resistance increases the risk for cardiovascular disease (CVD) even in the absence of classic risk factors, such as hyperglycemia, hypertension, dyslipidemia, and obesity. …”
    Get full text
    Article
  8. 1108

    Association of Biomarker Level with Cardiovascular Events: Results of a 4-Year Follow-Up Study by L. Turgunova, B. Baidildina, Y. Laryushina, B. Koichubekov, A. Turmukhambetova, L. Akhmaltdinova

    Published 2020-01-01
    “…Given the high rates of morbidity and mortality from cardiovascular disease (CVD), the primary and secondary CVD prevention is one of the public health priority. …”
    Get full text
    Article
  9. 1109

    Impact of maternal prenatal stress by glucocorticoids on metabolic and cardiovascular outcomes in their offspring: A systematic scoping review. by Claudia Eberle, Teresa Fasig, Franziska Brüseke, Stefanie Stichling

    Published 2021-01-01
    “…However, maternal risk factor "stress", is clearly linked to adverse cardio-metabolic offspring outcomes, postnatally, such as obesity, hyperglycemia, insulin resistance, diabetes mellitus (DM), Metabolic Syndrome (MetS), cardiovascular disease (CD), hypertension, restricted fetal growth as well as reduced birth, adrenal, and pancreas weights.…”
    Get full text
    Article
  10. 1110

    An overview of potential cardioprotective benefits of xanthophylls in atherosclerosis: an evidence-based review by Yuting Su, Feng Chen, Jiehua Chen, Mingfu Wang

    Published 2024-07-01
    “…Atherosclerosis, as the most prevalent form of cardiovascular disease, is characterized by oxidized lowdensity lipoprotein (ox-LDL) accumulation in the vascular wall, increased inflammation of the large arteries, dysfunction of the endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), which may eventually lead to the formation of plaques. …”
    Get full text
    Article
  11. 1111

    Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey by Guy De Backer, Robert J. Petrella, Assen R. Goudev, Ghazi Ahmad Radaideh, Andrzej Rynkiewicz, Atul Pathak

    Published 2013-01-01
    “…High blood pressure is a substantial risk factor for cardiovascular disease. Design & Methods. The Physicians' Observational Work on patient Education according to their vascular Risk (POWER) survey was an open-label investigation of eprosartan-based therapy (EBT) for control of high blood pressure in primary care centers in 16 countries. …”
    Get full text
    Article
  12. 1112

    Risk Factors and Consequent Diseases of Atherosclerosis in a Population Treated in a Medical Office by Luis Ángel Felicó Riverón, Georgia Díaz-Perera Fernández, Yomeidis Felicó Riverón

    Published 2024-11-01
    “…Altered waist circumference has the highest risk associated with peripheral arterial disease; high blood pressure with cardiovascular disease and peripheral arterial disease; and diabetes and dyslipidemia with chronic kidney disease.…”
    Get full text
    Article
  13. 1113

    Conducting genetic epidemiology research on hyperuricaemia and gout in an indigenous community in Guam - a feasibility study by Yvette C. Paulino, Frank Camacho, Tristan VC Paulino, Delores J. Lee, Lisa Linda Natividad, Elizabeth Matisoo-Smith, Tony R. Merriman, Anna L. Gosling

    Published 2025-02-01
    “…The prevalence of metabolic conditions from highest to lowest were obesity (55.6%), hyperuricaemia (36.0%), hypertension (27.8%), gout (23.0%), diabetes (14.9%), cardiovascular disease (8.4%), kidney disease (7.3%), and liver disease (3.4%). …”
    Get full text
    Article
  14. 1114

    Evolving View of Coronary Artery Calcium: A Personalized Shared Decision-Making Tool in Primary Prevention by Omar Dzaye, Cara Reiter-Brennan, Albert D. Osei, Olusola A. Orimoloye, S. M. Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael J. Blaha

    Published 2019-01-01
    “…Specifically, the current prevention guideline recommends CAC testing for primary atherosclerotic cardiovascular disease (ASCVD) prevention among asymptomatic patients in borderline and intermediate risk groups (5–7.5% and 7.5–20% 10-year ASCVD risk). …”
    Get full text
    Article
  15. 1115

    Mean Platelet Volume in Ocular Behçet’s Disease by Fatih Mehmet Türkcü, Abdullah Kürşat Cingü, Harun Yüksel, Yasin Çınar, Meltem Akkurt, Muhammed Şahin, Zeynep Özkurt, Alparslan Şahin, İhsan Çaça

    Published 2013-01-01
    “…These patients had no past history of smoking, drug use, or systemic diseases including diabetes mellitus, hypertension, cardiovascular disease, and renal disease. A control group consisting of 34 healthy individuals was included for comparison. …”
    Get full text
    Article
  16. 1116

    Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation by Derralynn Hughes, Andrew Lenny, Koonal Shah, Louise Longworth, Giovanna Devercelli, Olulade Ayodele

    Published 2023-04-01
    “…The interviewees' responses, evidence from published literature, and input from a clinical expert informed the development of 6 health state vignettes (pain, moderate clinically evident FD \[CEFD\], severe CEFD, end-stage renal disease \[ESRD\], stroke, and cardiovascular disease \[CVD\]) and 3 combined health states (severe CEFD + ESRD, severe CEFD + CVD, and severe CEFD + stroke). …”
    Get full text
    Article
  17. 1117

    Effects of 6 Months of Active Commuting and Leisure-Time Exercise on Fibrin Turnover in Sedentary Individuals with Overweight and Obesity: A Randomised Controlled Trial by Anne Sofie Gram, Martin Bæk Petersen, Jonas Salling Quist, Mads Rosenkilde, Bente Stallknecht, Else-Marie Bladbjerg

    Published 2018-01-01
    “…Obesity and exercise constitute important factors for cardiovascular disease risk, but the long-term effects of different exercise modalities on haemostatic biomarkers are not well elucidated. …”
    Get full text
    Article
  18. 1118

    Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes by Bethany Murphy, Simran Chahal, Elleigh Shepherd, Nicole Taylor, Austin Camp

    Published 2025-01-01
    “…Purpose: In the treatment of type 2 diabetes mellitus (T2DM), select sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are recommended based on comorbidities such as chronic kidney disease (CKD), heart failure (HF), and atherosclerotic cardiovascular disease (ASCVD). Because guidelines typically recommend insulin for inpatient treatment of T2DM, there is potential these therapies may be negatively impacted by hospitalization. …”
    Get full text
    Article
  19. 1119

    GLIM criteria for definition of malnutrition in peritoneal dialysis: a new aspect of nutritional assessment by Dao Wang, Jun Yin, Wen Liao, Xiaoran Feng, Fengping Zhang

    Published 2024-12-01
    “…In sensitivity analyses, the HR remained robust except the cardiovascular disease subgroup. The area under the curve of GLIM predicting 5-year mortality was 0.65 (0.62–0.68, p < 0.001). …”
    Get full text
    Article
  20. 1120

    Acute Myocardial Infarction and Predisposing Risk Factors by Julio Armando Sánchez Delgado, Nailé Edita Sánchez Lara, Yalith Pavón Rodríguez, Zulema Castro Vega

    Published 2023-11-01
    “…The risk factors, arterial hypertension (X2=25.4 OR=14 95 % CI (4.6; 42.3) and family history of cardiovascular disease (X2=5.2 OR=2.9 95 % CI (1, 1; 7.4)) expressed a highly significant association for acute myocardial infarction. …”
    Get full text
    Article